RESTON, Va., Oct. 13, 2025 /PRNewswire/ -- V2X, Inc. (VVX) will showcase its mission-focused capabilities at the 2025 Association of the United States Army (AUSA) Annual Meeting, taking place Monday, ...
Tempest Therapeutics, Inc. (TPST) has been able to make significant progress in advancing the use of its lead drug TPST-1120 for the treatment of patients with advanced solid tumors. In particular, it ...
-This aircraft, expected to be operational by 2035, will feature advanced technologies like deep learning AI, drone swarm coordination, directed-energy weapons, a virtual cockpit in-helmet, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback